Please note - a separate email address is required for each medical professional attending the program.
Screening, Diagnosis, and Treatment of Pulmonary Arterial Hypertension: An Overview
Presenter:
Vallerie V. McLaughlin, MD, FACC, FAHA, FCCP
Kim A. Eagle Endowed Professor and Associate Chief of Cardiovascular Medicine
Director, Pulmonary Hypertension Program
Michigan Medicine
Ann Arbor, Michigan
Target Audience
This activity has been designed for pulmonologists, cardiologists, rheumatologists, internists, and primary care physicians, as well as nurses, physician assistants, and other allied health professionals who help care for patients with pulmonary arterial hypertension (PAH).
Educational Objectives
This CME program is designed to improve competence, performance, and patient care practices by instructing clinicians in the highest quality of care for patients with PAH. At the conclusion of the program, participants should be able to:
- Accurately diagnose patients through comprehensive screening and early recognition of symptoms
- Evaluate the patient’s condition and prescribe optimal long-term management, including knowing when and how to treat and when to consult with colleagues at an established PAH center
 |
Accreditation
In support of improving patient care, this activity has been planned and implemented by Washington University School of Medicine in St. Louis, Continuing Medical Education and the Pulmonary Hypertension Association. Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
 |
Credit Awarded for This Activity
Washington University School of Medicine in St. Louis designates this internet live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
Disclosure Statement
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, that planners, faculty and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests in order for CME staff to identify and resolve any potential conflicts of interest prior to the educational activity. Faculty must also disclose any planned discussion of unlabled/unapproved uses of drugs or devices during their presentation. Detailed disclosures will be made in activity handout materials.
On-Demand Medical Education Program Committee Members
Deborah J. Levine, MD, FCCP, FAST (Committee Chair), Stanford School of Medicine; James R. Runo, MD, University of Wisconsin School of Medicine and Public Health; Marc Simon, MD, MS, FACC, UCSF School of Medicine; K. Akaya Smith, MD, Perelman School of Medicine at the University of Pennsylvania; Vallerie V. McLaughlin, MD, FACC, FAHA, FCCP (Advisor), Michigan Medicine
Washington University School of Medicine in St. Louis, CME Reviewers
Murali M. Chakinala, MD, FCCP — Content
Allyson R. Zazulia, MD — CME
This activity is supported by unrestricted educational grants from:
Platinum Supporter
Janssen Pharmaceuticals, Inc. |
Gold Supporter
United Therapeutics Corporation |
Bronze Supporter
Bayer Healthcare |
